Skip to menu Skip to content Skip to footer

2002

Journal Article

Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?

Johnson, David W., Nicol, David L., Purdie, David M., Preston, John M., Brown, Allison M., Hawley, Carmel M., Campbell, Scott B., Wall, Darryl, Griffin, Anthony D. and Isbel, Nicole M. (2002). Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?. Transplantation, 73 (7), 1158-1163.

Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?

2001

Journal Article

A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients

Johnson, David W., Herzig, Karen A., Gissane, Ruth, Campbell, Scott B., Hawley, Carmel M. and Isbel, Nicole M. (2001). A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients. Nephrology Dialysis Transplantation, 16 (9), 1879-1884. doi: 10.1093/ndt/16.9.1879

A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients

2001

Journal Article

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

Herzig, K. A., Purdie, D. M., Chang, W., Brown, A. M., Hawley, C. M., Campbell, S. B., Sturtevant, J. M., Isbel, N. M., Nicol, D. L. and Johnson, D. W. (2001). Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?. Journal of the American Society of Nephrology, 12 (4), 814-821.

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

2001

Journal Article

Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?

Kennedy, Robert, Case, Colin, Fathi, Robert, Johnson, David, Isbel, Nicole and Marwick, Thomas H. (2001). Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?. American Journal of Medicine, 110 (3), 198-204. doi: 10.1016/S0002-9343(00)00695-1

Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?

2001

Journal Article

Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation

Jonsson, Julie R., Hong, Cui, Purdie, David M., Hawley, Carmel, Isbel, Nicky, Butler, Maree, Balderson, Glenda A., Clouston, Andrew D., Pandeya, Nirmala, Stuart, Katherine, Edwards-Smith, Catherine, Crawford, Darrel H., Fawcett, Jonathon and Powell, Elizabeth E. (2001). Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation. Liver Transplantation, 7 (3), 255-263. doi: 10.1053/jlts.2001.22450

Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation

2000

Journal Article

Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients

Johnson, David W., Kay, Troy D., Vesey, David A., Isbel, Nicole, Campbell, Scott B. and Hawley, Carmel M. (2000). Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients. Peritoneal Dialysis International, 20 (6), 766-771.

Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients